For Admin
A Leading Company in Nasal Drug Delivery
SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.
3D Nasal Cast Model
August 02, 2021
Satsuma Pharmaceuticals Announces First Subject Randomized in the Phase 3 SUMMIT™ Efficacy Trial of STS101 for Acute Treatment of Migraine
June 17, 2021
Satsuma Pharmaceuticals, Inc. Announces Positive PK, Tolerability, and Safety Results From Phase 1 Trial of STS101 at Multiple Dose Strengths
March 02, 2021
Satsuma Pharmaceuticals, Inc. Announces Updated STS101 Development Plan
2024|2023|2022|2021|2020|2019|2018|2016|2015|2014|2013|2012〜